What is Biolinq worth?
$407.0Mlast known valuation
Biolinq last raised $90.0M in its Later Stage VC (Mar 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 36 names
- ·Watchlist + deal alerts for Biolinq
Create free account
No card required
Funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Later Stage VC | $90.0M | ▮ | ▮ |
| Dec 2023 | Debt | $59.1M | ▮ | ▮ |
| Sep 2021 | Later Stage VC | $77.9M | ▮ | ▮ |
| Mar 2021 | Debt | $5.2M | ▮ | ▮ |
| Mar 2020 | Debt | $3.6M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.0M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
How Biolinq's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biolinq, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Biolinq worth?
- Biolinq's last known valuation is $407.0M.
- How much has Biolinq raised?
- Biolinq has raised $312.8M in total funding across 8 recorded rounds.
- When did Biolinq last raise?
- Biolinq last raised in Mar 2025 (Later Stage VC), raising $90.0M.